Michael L Wang (Michael Wang, Simon Rule, L Michael Wang, Lai Wang)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 81

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Positron Emission Tomography

Top Venues

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Chijioke Nze, Clark R Andersen, Amy Ayers, Jason R Westin, Michael L Wang, Swaminathan P Iyer, Sairah A Ahmed, Chelsea C Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J Nastoupil, Kehe Zhang, Cici X Bauer, Christopher R Flowers
Impact of Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation in Non-Hodgkin Lymphoma. Blood advances (2024)
Chijioke Nze, Clark R Andersen, Amy A Ayers, Jason R Westin, Michael L Wang, Swaminathan Iyer, Sairah A Ahmed, Chelsea Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J Nastoupil, Kehe Zhang, Cici X Bauer, Christopher R Flowers
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL. Blood advances 8 (14) (2024)
Michael L Wang, Tadeusz Robak, Kami J Maddocks, Tycel Jovelle Phillips, Stephen Douglas Smith, David Gallinson, Roser Calvo, Chuan-Chuan Wun, Veerendra Munugalavadla, Wojciech Jurczak
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis. Blood advances (2024)
Chijioke Nze, Clark R Andersen, Amy A Ayers, Jason R Westin, Michael L Wang, Swaminathan Iyer, Sairah A Ahmed, Chelsea Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J Nastoupil, Kehe Zhang, Cici X Bauer, Christopher R Flowers
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL. Blood advances 8 (14) (2024)
Michael L Wang, Tadeusz Robak, Kami J Maddocks, Tycel Jovelle Phillips, Stephen D Smith, David Gallinson, Roser Calvo, Chuan-Chuan Wun, Veerendra Munugalavadla, Wojciech Jurczak
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis. Blood advances 8 (17) (2024)
Chijioke Nze, Clark R Andersen, Amy A Ayers, Jason R Westin, Michael L Wang, Swaminathan Iyer, Sairah A Ahmed, Chelsea Pinnix, Francisco Vega, Lynne Nguyen, Lorna McNeill, Loretta J Nastoupil, Kehe Zhang, Cici X Bauer, Christopher R Flowers
Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL. Blood advances 8 (14) (2024)
Michael L Wang, Tadeusz Robak, Kami J Maddocks, Tycel Jovelle Phillips, Stephen D Smith, David Gallinson, Roser Calvo, Chuan-Chuan Wun, Veerendra Munugalavadla, Wojciech Jurczak
Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis. Blood advances 8 (17) (2024)
Michael L Wang
Express Delivery of Next-Generation CAR T Cells with Preserved Naive and Stemness Phenotypes for the Treatment of Aggressive Lymphomas. Cancer discovery 13 (9) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Michael L Wang, Tanya Siddiqi, Leo I Gordon, Manali Kamdar, Matthew Lunning, Alexandre V Hirayama, Jeremy S Abramson, Jon Arnason, Nilanjan Ghosh, Amitkumar Mehta, Charalambos Andreadis, Scott R Solomon, Ana Kostic, Christine Dehner, Ricardo Espinola, Lily Peng, Ken Ogasawara, Amy Chattin, Laurie Eliason, Maria Lia Palomba
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma (MCL): Primary Analysis of the MCL Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Michael L Wang, Wojciech Jurczak, Pier Luigi Luigi Zinzani, Toby Andrew Eyre, Chan Yoon Y Cheah, Chaitra S Ujjani, Youngil Koh, Koji Izutsu, James N Gerson, Ian W Flinn, Benoît Tessoulin, Alvaro J Alencar, Shuo Ma, David John Lewis, Ewa Lech-Maranda, Joanna M Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S Tam, Tahla Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S Fenske, John Francis Seymour, Andrew D Zelenetz, Binoj Nair, Donald E Tsai, Minna Balbas, Richard A Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R Mato, Nirav N Shah
Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yuxuan Che, Yang Liu, Yijing Li, Joseph McIntosh, Alexa Jordan, Fangfang Yan, Wei Wang, Lei Nie, Heng-Huan Lee, Jingling Jin, Yixin Yao, Zhong-Ming Zhao, Vivian Changying Jiang, Michael L Wang
Dual targeting of CDK4/6 and Bcl-2 exhibits a potent anti-tumor effect on mantle cell lymphoma. Blood advances (2023)
Dongfeng Zeng, Yu Fang, Yue Fei, Rong Liang, Haige Ye, Yun Liang, Xiuhua Sun, Michael L Wang, Huiqiang Huang, Lugui Qiu, Yuxuan Che, Panpan Liu, Yi Wang, Tao Pan, Yao Lv, Jintai Deng, Shuhua Yi, Yizi He, Ling Xiao, Huijuan Lv, Jiangfang Feng, Huilai Zhang, Hui Zhou, Dehui Zou, Qing-Qing Cai
Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE. International journal of cancer (2023)
Christoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Matthias A Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia-Chi Chang, Lauren McDaniel, Ivonne Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis E Fayad, Sairah Ahmed, Swaminathan P Iyer, Raphael E Steiner, Preetesh Jain, Loretta J Nastoupil, Jason R Westin, Reetakshi Arora, Michael L Wang, Joel Turner, Meghan Menges, Melanie Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Muller-Tidow, Frederick L Locke, Marco L Davila, Richard E Champlin, Christopher R Flowers, Elizabeth J Shpall, Hendrik Poeck, Sattva S Neelapu, Michael Schmitt, Marion Subklewe, Michael D Jain, Robert R Jenq, Eran Elinav
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nature medicine (2023)
Yucai Wang, Preetesh Jain, Frederick L Locke, Matthew John Maurer, Matthew J Frank, Javier L Muñoz, Saurabh Dahiya, Amer M Beitinjaneh, Miriam T Jacobs, Joseph P McGuirk, Julie M Vose, Andre H Goy, Charalambos Andreadis, Brian T Hill, Kathleen A Dorritie, Olalekan O Oluwole, Abhinav Deol, Jonas Paludo, Bijal Shah, Trent P Wang, Rahul Banerjee, David Bernard Miklos, Aaron P Rapoport, Lazaros Lekakis, Armin Ghobadi, Sattva S Neelapu, Yi Lin, Michael L Wang, Michael D Jain
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yuqin Song, Ke-Shu Zhou, Dehui Zou, Dengju Li, Jian-da Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Dao-Bin Zhou, Constantine S Tam, David Simpson, Michael L Wang, Tycel J Phillips, Stephen Samuel Opat, Cheng Fang, Shaohui Sun, Jun Zhu
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis. Cancer medicine (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Yijing Li, Heng-Huan Lee, Vivian Changying Jiang, Yuxuan Che, Joseph McIntosh, Alexa Jordan, Jovanny Vargas, Tianci Zhang, Fangfang Yan, Margaret Elizabeth Simmons, Wei Wang, Lei Nie, Yixin Yao, Preetesh Jain, Michael L Wang, Yang Liu
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins. Cell death & disease 14 (11) (2023)
Jeremy S Abramson, M Lia Palomba, Leo I Gordon, Matthew A Lunning, Michael L Wang, Jon E Arnason, Enkhtsetseg Purev, David G Maloney, Charalambos Babis Andreadis, Alison Sehgal, Scott R Solomon, Nilanjan Ghosh, Christine Dehner, Yeonhee Kim, Ken Ogasawara, Ana Kostic, Tanya Siddiqi
Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001. Blood (2023)
James N Gerson, Elizabeth Handorf, Diego R Villa, Alina S Gerrie, Parv Chapani, Shaoying Li, L Jeffrey Medeiros, Michael L Wang, Jonathan Cohen, Michael C Churnetski, Brian T Hill, Yazeed Sawalha, Francisco J Hernandez-Ilizaliturri, Shalin K Kothari, Julie M Vose, Martin A Bast, Timothy S Fenske, Swapna Narayana Rao Gari, Kami J Maddocks, David A Bond, Veronika Bachanova, Bhaskar C Kolla, Julio C Chavez, Bijal D Shah, Frederick Lansigan, Timothy F Burns, Alexandra Donovan, Nina D Wagner-Johnston, Marcus Raymond Messmer, Amitkumar Mehta, Jennifer Anderson, Nishitha Reddy, Alexandra Kovach, Daniel J Landsburg, Martha J Glenn, David J Inwards, Kay Ristow, Reem Karmali, Jason Kaplan, Paolo F Caimi, Saurabh A Rajguru, Andrew M Evens, Andreas K Klein, Elvira Umyarova, Bhargavi Pulluri, Jennifer Effie Amengual, Jenniver K Lue, Catherine Diefenbach, Richard I Fisher, Stefan K Barta
Outcomes of Patients with Blastoid and Pleomorphic Variant Mantle Cell Lymphoma. Blood advances (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Holly A Hill, Preetesh Jain, Chi Young Ok, Koiji Sasaki, Han-Yang Chen, Michael L Wang, Ken Chen
Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma. Cancer research communications 3 (8) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Tanya Siddiqi, Steven Coutre, Matthew McKinney, Paul M Barr, Kerry Rogers, Ahmad Mokatrin, Rudy Valentino, Anita Szoke, Sanjay Deshpande, Angeline Zhu, Israel Arango-Hisijara, Kojo Osei-Bonsu, Michael L Wang, Susan O'Brien
Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma. Leukemia & lymphoma 63 (7) (2022)
Vivian Changying Jiang, Yang Liu, Alexa Jordan, Angela Leeming, Joseph McIntosh, Shengjian Huang, Rongjia Zhang, Qingsong Cai, Zhihong Chen, Yijing Li, Yuxuan Che, Lei Nie, Ingrid Karlsson, Linda Mårtensson, Mathilda Kovacek, Ingrid Teige, Björn Frendéus, Michael L Wang
Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma. Journal of hematology & oncology 15 (1) (2022)
Peter Martin, Jonathon B Cohen, Michael L Wang, Anita Kumar, Brian Hill, Diego R Villa, Jeffrey M Switchenko, Brad S Kahl, Kami Maddocks, Natalie Sophia Grover, Keqin Qi, Lori Parisi, Katherine Daly, Angeline Zhu, Gilles Andre Salles
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Yucai Wang, Shouhao Zhou, Xinyue Qi, Fang Yang, Matthew John Maurer, Thomas M Habermann, Thomas E Witzig, Michael L Wang, Grzegorz S Nowakowski
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials. Blood cancer journal 12 (1) (2022)
Jason R Westin, R Eric Davis, Lei Feng, Fredrick B Hagemeister, Raphael Steiner, Jee Hun Lee, Luis Fayad, Loretta Nastoupil, Sairah Ahmed, Maria A Rodriguez, Michelle Fanale, Felipe Samaniego, Swaminathan P Iyer, Ranjit Nair, Yasuhiro Oki, Nathan Fowler, Michael L Wang, Man Chun John Ma, Francisco Vega, Timothy McDonnell, Chelsea Pinnix, Donna Griffith, Yang Lu, Sanjit O Tewari, Ryan Sun, David W Scott, Christopher R Flowers, Sattva S Neelapu, Michael R Green
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Michael L Wang, Wojciech Jurczak, Mats Jerkeman, Judith Trotman, Pier L Zinzani, David Belada, Carola Boccomini, Ian W Flinn, Pratyush Giri, Andre Goy, Paul A Hamlin, Olivier Hermine, José-Ángel Hernández-Rivas, Xiaonan Hong, Seok Jin Kim, David Lewis, Yuko Mishima, Muhit Özcan, Guilherme F Perini, Christopher Pocock, Yuqin Song, Stephen E Spurgeon, John M Storring, Jan Walewski, Jun Zhu, Rui Qin, Todd Henninger, Sanjay Deshpande, Angela Howes, Steven Le Gouill, Martin Dreyling, null null
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma. The New England journal of medicine 386 (26) (2022)
Michael L Wang, Javier L Muñoz, Andre H Goy, Frederick L Locke, Caron A Jacobson, Brian T Hill, John M Timmerman, Houston Holmes, Samantha Jaglowski, Ian W Flinn, Peter A McSweeney, David Bernard Miklos, John M Pagel, Marie José Kersten, Krimo Bouabdallah, Rashmi Khanal, Max S Topp, Houot Roch, Amer Beitinjaneh, Weimin Peng, Xiang Fang, Rhine R Shen, Rubina Siddiqi, Ioana Kloos, Patrick M Reagan
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Preetesh Jain, Michael L Wang
Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments. American journal of hematology 97 (5) (2022)
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, Junsheng Ma, Romil D Patel, Kartik Devashish, Kaberi Das, Mark R Tanner, Paolo Strati, Ranjit Nair, Luis Fayad, Sairah A Ahmed, Hun Ju Lee, Swaminathan P Iyer, Raphael E Steiner, Nitin Jain, Loretta Nastoupil, Sanam Loghavi, Guilin Tang, Roland L Bassett, Preetesh Jain, Michael L Wang, Jason R Westin, Michael R Green, David A Sallman, Eric Padron, Marco L Davila, Frederick L Locke, Richard E Champlin, Guillermo Garcia-Manero, Elizabeth J Shpall, Partow Kebriaei, Christopher R Flowers, Michael D Jain, Feng Wang, Andrew P Futreal, Nancy Gillis, Sattva S Neelapu, Koichi Takahashi
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma. Blood cancer discovery 3 (5) (2022)
Hua-Jay J Cherng, Guofan Xu, Lei Feng, Raphael Steiner, Luis Fayad, Paolo Strati, Ranjit Nair, Loretta J Nastoupil, Jee Hun Lee, Sattva S Neelapu, Christopher R Flowers, Maria Rodriguez, Michael L Wang, Fredrick Hagemeister, Chelsea C Pinnix, Jeremy Ramdial, Samer A Srour, Yago L Nieto, Katayoun Rezvani, Richard Champlin, Partow Kebriaei, Jason Westin, Homer A Macapinlac, Elizabeth Shpall, Sairah A Ahmed
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant. British journal of haematology (2022)
Svenja Petersohn, Gilles Andre Salles, Michael L Wang, James J Wu, Sally W Wade, Claire L Simons, Craig Bennison, Rubina Siddiqi, Weimin Peng, Ioana Kloos, Gab Castaigne, Georg Hess
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England. Journal of medical economics 25 (1) (2022)
Toby Andrew Eyre, Chan Yoon Y Cheah, Michael L Wang
Therapeutic options for relapsed/refractory mantle cell lymphoma. Blood (2021)
Diana Martinez-Baquero, Ali Sakhdari, Huan Mo, Do Hwan Kim, Rashmi Kanagal-Shamana, Shaoying Li, Ken H H Young, Dennis P O'Malley, Ahmet Dogan, Preetesh Jain, Michael L Wang, Timothy J McDonnell, Roberto N Miranda, Francisco Vega, L Jeffrey Medeiros, Chi Young Ok
EZH2 expression is associated with inferior overall survival in mantle cell lymphoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (12) (2021)
Vivian Changying Jiang, Yang Liu, Alexa Jordan, Joseph McIntosh, Yijing Li, Yuxuan Che, Katti A Jessen, Brian J Lannutti, Michael L Wang
The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma. Journal of hematology & oncology 14 (1) (2021)
Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Yang Liu, Rongjia Zhang, Joseph McIntosh, Ruiping Wang, Minghao Dang, Enyu Dai, Yuanxin Wang, David Santos, Maria Badillo, Angela Leeming, Zhihong Chen, Kimberly Hartig, John Bigcal, Jia Zhou, Rashmi Kanagal-Shamanna, Chi Young Ok, Hun Lee, Raphael E Steiner, Jianhua Zhang, Xingzhi Song, Ranjit Nair, Sairah Ahmed, Alma Rodriquez, Selvi Thirumurthi, Preetesh Jain, Nicolaus Wagner-Bartak, Holly A Hill, Krystle Nomie, Christopher Flowers, P Andrew Futreal, Linghua Wang, Michael L Wang
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma. Nature communications 12 (1) (2021)
Xiaoshan Zhang, Ran Zhang, Chenghui Ren, Yi Xu, Shuhong Wu, Carrie Meng, Apar Pataer, Xingzhi Song, Jianhua Zhang, Yixin Yao, Hua He, Huiqin Chen, Wencai Ma, Jing Wang, Funda Meric-Bernstam, Richard E Champlin, John V Heymach, Cliona M Rooney, Stephen G Swisher, Ara A Vaporciyan, Jack A Roth, M James You, Michael L Wang, Bingliang Fang
Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo. Blood advances (2021)
Richard R Furman, John C Byrd, Roger G Owen, Susan M O'Brien, Jennifer R Brown, Peter Hillmen, Deborah M Stephens, Nataliya Chernyukhin, Tamara Lezhava, Ahmed M Hamdy, Raquel Izumi, Priti Patel, Marshall Baek, Beth Christian, Martin J S Dyer, Matthew J Streetly, Clare Sun, Simon A Rule, Michael L Wang, Paolo Ghia, Wojciech Jurczak, John M Pagel, Jeff P Sharman
Pooled analysis of safety data from clinical trials evaluating acalabrutinib monotherapy in mature B-cell malignancies. Leukemia 35 (11) (2021)
Constantine S Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Munoz, Tycel J Phillips, Won Seog Kim, Simon Rule, Siminder Kaur Atwal, Rachel Wei, William Novotny, Jane Huang, Michael L Wang, Judith Trotman
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma. Blood advances 5 (12) (2021)
Claire L Simons, Daniel C Malone, Michael L Wang, Gregory A Maglinte, Timothy J Inocencio, Sally W Wade, Craig Bennison, Bijal D Shah
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States. Journal of medical economics 24 (1) (2021)
Preetesh Jain, Shuangtao Zhao, Jee Hun Lee, Holly A Hill, Chi Young Ok, Rashmi Kanagal-Shamana, Fredrick B Hagemeister, Nathan Fowler, Luis Fayad, Yixin Yao, Yang Liu, Omar B Moghrabi, Lucy Navsaria, Lei Feng, Graciela M Nogueras Gonzalez, Guofan Xu, Selvi Thirumurthi, David A Santos, Cezar Iliescu, Guillin Tang, L Jeffrey Medeiros, Francisco Vega, Michelle Avellaneda, Maria Badillo, Christopher R Flowers, Linghua Wang, Michael L Wang
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Ravi K Goyal, Preetesh Jain, Saurabh P Nagar, Hannah Le, Shaum M Kabadi, Keith Davis, James A Kaye, Xianglin L Du, Michael L Wang
Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma. Leukemia & lymphoma 62 (6) (2021)
Paolo Strati, Sairah A Ahmed, Fateeha Furqan, Luis E Fayad, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Loretta J Nastoupil, Simrit Parmar, Maria A Rodriguez, Felipe Samaniego, Raphael E Steiner, Michael L Wang, Chelsea C Pinnix, Sandra B Horowitz, Lei Feng, Ryan Sun, Catherine M Claussen, Misha C Hawkins, Nicole A Johnson, Prachee Singh, Haleigh Mistry, Swapna Johncy, Sherry Adkins, Partow Kebriaei, Elizabeth J Shpall, Michael R Green, Christopher R Flowers, Jason R Westin, Sattva S Neelapu
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma. Blood 137 (23) (2021)
Uri Greenbaum, Paolo Strati, Rima M Saliba, Janet Torres, Gabriela Rondon, Yago L Nieto, Chitra Hosing, Samer A Srour, Jason R Westin, Luis E Fayad, Hun J Lee, Swaminathan P Iyer, Ranjit Nair, Loretta J Nastoupil, Simrit Parmar, Maria A Rodriguez, Felipe Samaniego, Raphael E Steiner, Michael L Wang, Chelsea C Pinnix, Christopher R Flowers, Sudhakar Tummala, Jeremy L Ramdial, Fevzi F Yalniz, Misha Hawkins, Katayoun Rezvani, Richard E Champlin, Elizabeth J Shpall, Sattva S Neelapu, Partow Kebriaei, Sairah A Ahmed
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. Blood advances 5 (14) (2021)
Loretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, Felipe Samaniego, Nathan Hale Fowler, Jason R Westin, Hun Ju Lee, Michael L Wang, Fredrick Hagemeister, Alexander R L Cecil, James Dow, Kemal Haque, Franck A Silva, Andrew Whale, Letitia Lensun, Elisabeth A Bone, Hilary McElwaine-Johnn, Philip A Beer
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma. Leukemia & lymphoma (2021)
Michael L Wang, Radhakrishnan Ramchandren, Robert Chen, Lionel Karlin, Geoffrey Chong, Wojciech Jurczak, Ka Lung Wu, Mark Bishton, Graham P Collins, Paul Eliadis, Frédéric Peyrade, Yihua Lee, Karl Eckert, Jutta K Neuenburg, Constantine S Tam
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study. Journal of hematology & oncology 14 (1) (2021)
Pashna N Munshi, Mehdi Hamadani, Ambuj Kumar, Peter Dreger, Jonathan W Friedberg, Martin Dreyling, Brad Kahl, Mats Jerkeman, Mohamed A Kharfan-Dabaja, Frederick L Locke, Mazyar Shadman, Brian T Hill, Sairah A Ahmed, Alex F Herrera, Craig S Sauter, Veronika Bachanova, Nilanjan Ghosh, Matthew Lunning, Vaishalee P Kenkre, Mahmoud Aljurf, Michael L Wang, Kami J Maddocks, John P Leonard, Manali Kamdar, Tycel Phillips, Amanda F Cashen, David J Inwards, Anna Sureda, Jonathon B Cohen, Sonali M Smith, Carmello Carlo-Stella, Bipin Savani, Stephen P Robinson, Timothy S Fenske
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma. Bone marrow transplantation 56 (12) (2021)
Matthew S Ning, Chelsea C Pinnix, Bhavana V Chapman, Jillian R Gunther, Sarah A Milgrom, Joseph D Khoury, Preetesh Jain, Wendy Y Chen, Onyeka N Oriabure, Maria R Badillo, Michael L Wang, Bouthaina S Dabaja
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma. Blood advances 3 (13) (2020)
Elisabet E Manasanch, Preetesh Jain, Wendy Chen, Onyeka Oriabure, Maria Badillo, Lei Feng, Zuzana Berkova, Robert Z Orlowski, Michael L Wang
Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma. American journal of hematology 95 (9) (2020)
Enli Liu, David Marin, Pinaki Banerjee, Homer A Macapinlac, Philip Thompson, Rafet Basar, Lucila Nassif Kerbauy, Bethany Overman, Peter Thall, Mecit Kaplan, Vandana Nandivada, Indresh Kaur, Ana Nunez Cortes, Kai Cao, May Daher, Chitra Hosing, Evan N Cohen, Partow Kebriaei, Rohtesh Mehta, Sattva Neelapu, Yago Nieto, Michael L Wang, William Wierda, Michael Keating, Richard Champlin, Elizabeth J Shpall, Katayoun Rezvani
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors. The New England journal of medicine 382 (6) (2020)
Preetesh Jain, Guillin Tang, Shaoying Li, Michael L Wang
"Triple hit" SOX11- , MME+ , TP53 mutated high-grade pleomorphic mantle cell lymphoma. American journal of hematology 96 (1) (2020)
Michael L Wang, Javier Munoz, Andre Goy, Frederick L Locke, Caron A Jacobson, Brian T Hill, John M Timmerman, Houston Holmes, Samantha Jaglowski, Ian W Flinn, Peter A McSweeney, David B Miklos, John M Pagel, Marie-Jose Kersten, Noel Milpied, Henry Fung, Max S Topp, Roch Houot, Amer Beitinjaneh, Weimin Peng, Lianqing Zheng, John M Rossi, Rajul K Jain, Arati V Rao, Patrick M Reagan
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma. The New England journal of medicine 382 (14) (2020)
Lucy Navsaria, Alfonso Badillo, Michael L Wang
Second Cancers in a Patient with Gastric MALT Lymphoma. Case reports in medicine 2020 (2020)
Dayoung Jung, Preetesh Jain, Yixin Yao, Michael L Wang
Advances in the assessment of minimal residual disease in mantle cell lymphoma. Journal of hematology & oncology 13 (1) (2020)
Shijia Zhang, Amit A Kulkarni, Beibei Xu, Haitao Chu, Taxiarchis Kourelis, Ronald S Go, Michael L Wang, Veronika Bachanova, Yucai Wang
Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis. Blood cancer journal 10 (3) (2020)
Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, Chi Young Ok, Shaojun Zhang, Krystle Nomie, Guangchun Han, Dapeng Hao, Holly A Hill, Changying Jiang, Yixin Yao, Loretta Nastoupil, Jason Westin, Luis Fayad, Ranjit Nair, Raphel Steiner, Sairah Ahmed, Felipe Samaniego, Swaminathan P Iyer, Onyeka Oriabure, Wendy Chen, Xingzhi Song, Jianhua Zhang, Maria Badillo, Omar Moghrabi, Jorge Aranda, Guillin Tang, Cheng Cameron Yin, Keyur Patel, Leonard Jeffrey Medeiros, Shaoying Li, Francisco Vega, Selvi Thirumurthi, Guofan Xu, Sattva Neelapu, Christopher R Flowers, Jorge Romaguera, Nathan Fowler, Linghua Wang, Michael L Wang, Preetesh Jain
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. American journal of hematology 95 (6) (2020)
Wen-Hao Guo, Xiaoli Qi, Xin Yu, Yang Liu, Chan-I Chung, Fang Bai, Xingcheng Lin, Dong Lu, Lingfei Wang, Jianwei Chen, Lynn Hsiao Su, Krystle J Nomie, Feng Li, Meng C Wang, Xiaokun Shu, José N Onuchic, Jennifer A Woyach, Michael L Wang, Jin Wang
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry. Nature communications 11 (1) (2020)
Liang Zhang, Yixin Yao, Shaojun Zhang, Yang Liu, Hui Guo, Makhdum Ahmed, Taylor Bell, Hui Zhang, Guangchun Han, Elizabeth Lorence, Maria Badillo, Shouhao Zhou, Yuting Sun, Maria Emilia Di Francesco, Ningping Feng, Randy Haun, Renny Shang-Lun Lan, Samuel G Mackintosh, Xizeng Mao, Xingzhi Song, Jianhua Zhang, Lan V Pham, Philip L Lorenzi, Joseph R Marszalek, Timothy P Heffernan, Giulio F Draetta, Philip Jones, P Andrew Futreal, Krystle Nomie, Linghua Wang, Michael L Wang
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Science translational medicine 11 (491) (2020)
Jee Hun Lee, Jacob L Schmelz, Fred Cramer, Jorge E Romaguera, Maria Badillo, Michael L Wang
A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma. British journal of haematology 188 (6) (2020)
Paolo Strati, Seung Tae Lee, Purnima Teegavarupu, Anusha Karri, Saswatha Anireddy, Fredrick B Hagemeister, Jorge Romaguera, Luis E Fayad, Maria A Rodriguez, Felipe Samaniego, Nathan Fowler, Jason Westin, Michael L Wang, Hun Ju Lee, Chelsea Pinnix, Jillian R Gunther, Bouthaina Dabaja, Lei Feng, Richard Eric Davis, Sattva S Neelapu
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma. American journal of hematology 94 (6) (2019)
Jeffrey Wang, Jacqueline Wang, Elyse Lopez, Hui Guo, Hui Zhang, Yang Liu, Zhihong Chen, Shengjian Huang, Shouhao Zhou, Angela Leeming, R J Zhang, Dayoung Jung, Hannah Shi, Hadley Grundman, Darian Doakes, Kathleen Cui, Changying Jiang, Makhdum Ahmed, Krystle Nomie, Bingliang Fang, Michael L Wang, Yixin Yao, Liang Zhang
Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma. Blood cancer journal 9 (12) (2019)
Michael L Wang, Simon A Rule, Pier Luigi Zinzani, Andre Goy, Olivier Casasnovas, Stephen D Smith, Gandhi Damaj, Jeanette K Doorduijn, Thierry Lamy, Franck Morschhauser, Carlos Panizo, Bijal Shah, Andrew Davies, Richard Eek, Jehan Dupuis, Eric Jacobsen, Arnon P Kater, Steven Le Gouill, Lucie Oberic, Tadeusz Robak, Preetesh Jain, Melanie M Frigault, Raquel Izumi, Dorothy Nguyen, Priti Patel, Ming Yin, Monika Długosz-Danecka
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma. Leukemia 33 (11) (2019)
Hans C Lee, Jatin J Shah, Lei Feng, Elisabet E Manasanch, Rebecca Lu, Ashley Morphey, Brandon Crumpton, Krina K Patel, Michael L Wang, Raymond Alexanian, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma. Blood cancer journal 9 (10) (2019)
Hans C Lee, Jatin J Shah, Lei Feng, Ashley Morphey, Ralph J Johnson, Emily T Wesson, Michael L Wang, Raymond Alexanian, Sheeba K Thomas, Robert Z Orlowski, Donna M Weber
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. American journal of hematology 94 (12) (2019)
Makhdum Ahmed, Elizabeth Lorence, Jeffrey W Wang, Dayoung Jung, Liang Zhang, Krystle Nomie, Michael L Wang
Interrogating B cell signaling pathways: A quest for novel therapies for mantle cell lymphoma. Science signaling 12 (567) (2019)
Preetesh Jain, Michael L Wang
Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. American journal of hematology 94 (6) (2019)
Pamela McKay, Mike Leach, Bob Jackson, Stephen Robinson, Michael L Wang
Guideline for the management of mantle cell lymphoma. British journal of haematology 182 (1) (2018)
Jorge E Romaguera, Michael L Wang, Lei Feng, Luis E Fayad, Frederick Hagemeister, Peter McLaughlin, M Alma Rodriguez, Michelle Fanale, Robert Orlowski, Larry W Kwak, Sattva Neelapu, Yasuhiro Oki, Barbara Pro, Anas Younes, Felipe Samaniego, Nathan Fowler, Kimberly Hartig, Marisa Valentinetti, Judy Smith, Peggy Ford, Adam Naig, L Jeffrey Medeiros, Hagop M Kantarjian, Andre Goy
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma. Cancer 124 (12) (2018)
Shengjian Huang, Changying Jiang, Hui Zhang, Taylor Bell, Hui Guo, Yang Liu, Yixin Yao, Dongfeng Zeng, Makhdum Ahmed, Krystle Nomie, Leo Zhang, Michael L Wang
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma. Blood cancer journal 8 (3) (2018)
Pamela McKay, Mike Leach, Bob Jackson, Stephen Robinson, Michael L Wang
A British Society for haematology good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma. British journal of haematology 182 (1) (2018)
Carrie J Li, Changying Jiang, Yang Liu, Taylor Bell, Wencai Ma, Yin Ye, Shengjian Huang, Hui Guo, Hui Zhang, Michael L Wang, Krystle Nomie, Liang Zhang
Pleiotropic Action of Novel Bruton's Tyrosine Kinase Inhibitor BGB-3111 in Mantle Cell Lymphoma. Molecular cancer therapeutics 18 (2) (2018)
Haige Ye, Aakash Desai, Shengjian Huang, Dayoung Jung, Richard Champlin, Dongfeng Zeng, Fangfang Yan, Krystle Nomie, Jorge Romaguera, Makhdum Ahmed, Michael L Wang
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy. Journal of experimental & clinical cancer research : CR 37 (1) (2018)
Lan V Pham, Shengjian Huang, Hui Zhang, Jun Zhang, Taylor Bell, Shouhao Zhou, Elizabeth Pogue, Zhiyong Ding, Laura Lam, Jason Westin, R Eric Davis, Ken H Young, L Jeffrey Medeiros, Richard J Ford, Krystle Nomie, Leo Zhang, Michael L Wang
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (16) (2018)
Hui Guo, Dongfeng Zeng, Hui Zhang, Taylor Bell, Jun Yao, Yang Liu, Shengjian Huang, Carrie J Li, Elizabeth Lorence, Shouhao Zhou, Tiejun Gong, Vivian Changying Jiang, Makhdum Ahmed, Yixin Yao, Krystle J Nomie, Liang Zhang, Michael L Wang
Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma. Oncogene 38 (11) (2018)
Michael L Wang, Martin Dreyling, Andre Goy, Georg Hess, Rebecca Auer, Brad Kahl, Nora Cavazos, Black Liu, Shiyi Yang, Fong Clow, Jenna D Goldberg, Darrin Beaupre, Jessica Vermeulen, Mark Wildgust, Michael Wang
Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies. British journal of haematology 179 (3) (2017)
Haige Ye, Aakash Desai, Dongfeng Zeng, Krystle Nomie, Jorge Romaguera, Makhdum Ahmed, Michael L Wang
Smoldering mantle cell lymphoma. Journal of experimental & clinical cancer research : CR 36 (1) (2017)